For: | Ding YN, Xue M, Tang QS, Wang LJ, Ding HY, Li H, Gao CC, Yu WP. Immunotherapy-based novel nanoparticles in the treatment of gastrointestinal cancer: Trends and challenges. World J Gastroenterol 2022; 28(37): 5403-5419 [PMID: 36312831 DOI: 10.3748/wjg.v28.i37.5403] |
---|---|
URL: | https://www.wjgnet.com/2307-8960/full/v28/i37/5403.htm |
Number | Citing Articles |
1 |
Dong Zhang, Rui Sun, Chenyu Di, Lin Li, Faming Zhao, Yu Han, Wenjie Zhang. Microdissection of cancer-associated fibroblast infiltration subtypes unveils the secreted SERPINE2 contributing to immunosuppressive microenvironment and immuotherapeutic resistance in gastric cancer: A large-scale study integrating bulk and single-cell transcriptome profiling. Computers in Biology and Medicine 2023; 166: 107406 doi: 10.1016/j.compbiomed.2023.107406
|
2 |
Hanhee Cho, Kwangmeyung Kim. Multi-functional nanomedicines for combinational cancer immunotherapy that transform cold tumors to hot tumors. Expert Opinion on Drug Delivery 2024; 21(4): 627 doi: 10.1080/17425247.2024.2348656
|
3 |
Saul Yedgar, Gregory Barshtein, Alexander Gural. Hemolytic Activity of Nanoparticles as a Marker of Their Hemocompatibility. Micromachines 2022; 13(12): 2091 doi: 10.3390/mi13122091
|
4 |
Li-Xiang Ling, Yaobin Ouyang, Yi Hu. Research trends on nanomaterials in gastric cancer: a bibliometric analysis from 2004 to 2023. Journal of Nanobiotechnology 2023; 21(1) doi: 10.1186/s12951-023-02033-8
|
5 |
Xiaoshuang Wu, Jinghua Heng, Mengxiang Li, Danxia Deng, Bingli Wu, Muting Wang, Sanqiang Li, Shegan Gao, Yijun Qi, Enmin Li. The prognostic value of microRNA‐200 family expression in digestive system tumors: A meta‐analysis and validation. MedComm – Oncology 2024; 3(3) doi: 10.1002/mog2.86
|